Harrow Health(IMMY)

Imprimis Pharmaceuticals和 Compounding Pharmacy

淘沙见金2017-10-30 11:45

这个制药公司Imprimis Pharmaceuticals $Imprimis Pharmaceuticals, Inc.(IMMY)$ 大涨，原因是因为公司称将会提供比AGN的干眼症治疗药物Restasis更为便宜的替代选择。这个药物第一个月只需要不到1美元，以后每个月花费79美元。对比Restasis每年的花费高达5000美元一年确实便宜不少。听起来很美好...查看全文

Vodka配鱼油救命药2017-10-20 09:45

$Imprimis Pharmaceuticals, Inc.(IMMY)$
IMMY买入原因：今天IMMY发的干眼症药物为Restasis的仿制药，RESTASIS 2016年第三季度全球销售额为371.6million, 第四季度全球销售额393.1 million占干眼症市场的80%，现有竞争对手仅有Shire’s idra，占20%的市场。IMMY的仿制药由于是走低价路线，有可...查看全文

TLS美股研究2017-04-09 21:31

回复@panderson: $IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 我们看看。我刚打赏了这条评论 ¥2.88，也推荐给你。//@panderson:回复@TLS美股研究:IMMY值得关注，眼科市场天花板逐渐打开，公司高管参与增发，市值迷你，会是小黑马吗 查看全文

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2016-11-15 AccNo: 0001493152-16-014994 Size: 2 MBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-11-14 AccNo: 0001493152-16-014931 Size: 5 MB 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2016-11-09 AccNo: 0001493152-16-014677 Size: 25 KBItem 8.01: Other Events 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 美东时间 2016-11-14 16:30 After Market Close:IMPRIMIS PHARMA Earning Release 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2016-09-26 AccNo: 0001493152-16-013576 Size: 19 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers http...

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2016-09-14 AccNo: 0001493152-16-013306 Size: 24 KBItem 8.01: Other Events 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-08-30 AccNo: 0001493152-16-012984 Size: 109 KB 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2016-08-15 AccNo: 0001493152-16-012438 Size: 105 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-08-15 AccNo: 0001493152-16-012435 Size: 4 MB 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2016-08-11 AccNo: 0001493152-16-012225 Size: 130 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.01: Completion of Acquisition or Disposition of AssetsItem 2.03: Creation of a Direct Financial Obli...